IBRX — IMMUNITYBIO INC

Ownership history in SHEETS SMITH WEALTH MANAGEMENT  ·  20 quarters on record

This page tracks every 13F SEC filing in which SHEETS SMITH WEALTH MANAGEMENT reported a position in IMMUNITYBIO INC (IBRX). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
1.23% (2022 Q4)
Avg. % of fund
0.26%
First filed
2021 Q1
Last filed
2025 Q4
Quarters held
20
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 REDUCED 631,975 -1,100 -0.2% 0.14% $1.3M $1.98
2025 Q3 REDUCED 633,075 -400 -0.1% 0.18% $1.6M $2.46
2025 Q2 UNCHANGED 633,475 — 0% 0.20% $1.7M $2.64
2025 Q1 REDUCED 633,475 -500 -0.1% 0.24% $1.9M $3.01
16 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    IBRX price (monthly, adj. close)

Other funds also holding IBRX

As of 2025 Q4 — sorted by position size

Kercheville Advisors, LLC 3Y 1.12% Winning Points Advisors, LLC 3Y 0.54% TANG CAPITAL MANAGEMENT LLC 3Y 7Y 0.23% Accurate Wealth Management, LLC 3Y 0.17% Virtus Investment Advisers, LLC 3Y 7Y 0.16% Clearwater Capital Advisors, LLC 3Y 7Y 0.14% AlphaCore Capital LLC 3Y 0.13% ALLEN HOLDING INC /NY 3Y 7Y 0.13% COLLECTIVE FAMILY OFFICE LLC 3Y 0.07% Voleon Capital Management LP 3Y 7Y 0.06%
← Back to SHEETS SMITH WEALTH MANAGEMENT Holdings